Sera Prognostics, Inc.

    Jurisdiction
    United States
    ISIN
    US81749D1072 (SERA)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €93.05K
    Gross margin
    -209.3%
    EBIT
    -€31.75M
    EBIT margin
    -34,125.0%
    Net income
    -€28.20M
    Net margin
    -30,306.5%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Mirza Mansoor Raza N/A -222 $3.35 -$743.70
    Kearney Paul Chief Data Officer -1.5K $3.49 -$5.09K
    Kearney Paul Chief Data Officer -11K $3.49 -$36.79K
    Harrison Robert Gardner Chief Information Officer -6K $2.22 -$13.32K
    Aerts Austin Chief Financial Officer -5.8K $2.54 -$14.73K

    Earnings Calls

    Latest earnings call: May 8, 2024

    Add to watchlist

    Notifications